The intrinsic enzymatic activity of procarboxypeptidase U (TAFI) does not significantly influence the fibrinolytic rate: reply to a rebuttal
- 1 June 2007
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 5 (6) , 1336-1337
- https://doi.org/10.1111/j.1538-7836.2007.02593.x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The intrinsic enzymatic activity of procarboxypeptidase U (TAFI) does not significantly influence the fibrinolysis rate: a rebuttalJournal of Thrombosis and Haemostasis, 2007
- Thrombin-activable Fibrinolysis Inhibitor (TAFI) Zymogen Is an Active CarboxypeptidasePublished by Elsevier ,2007
- The intrinsic enzymatic activity of plasma procarboxypeptidase U (TAFI) can interfere with plasma carboxypeptidase N assaysAnalytical Biochemistry, 2006
- Post-translational Modifications of Human Thrombin-Activatable Fibrinolysis Inhibitor (TAFI): Evidence for a Large Shift in the Isoelectric Point and Reduced Solubility upon ActivationBiochemistry, 2006
- The molecular physiology and pathology of fibrin structure/functionBlood Reviews, 2005
- Roles of Thermal Instability and Proteolytic Cleavage in Regulation of Activated Thrombin-activable Fibrinolysis InhibitorJournal of Biological Chemistry, 2000
- The Contribution of Activated Factor XIII to Fibrinolytic Resistance in Experimental Pulmonary EmbolismCirculation, 1999
- Human Procarboxypeptidase U, or Thrombin-activable Fibrinolysis Inhibitor, Is a Substrate for TransglutaminasesJournal of Biological Chemistry, 1998
- Fibrin assembly. Lateral aggregation and the role of the two pairs of fibrinopeptidesBiophysical Journal, 1986
- Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.Journal of Clinical Investigation, 1980